Japan Macular Degeneration (AMD) and Other Retinal Diseases Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.0 Billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030.
Japan's Macular Degeneration (AMD) and other retinal diseases market have shown significant growth in recent years. Age-related macular degeneration (AMD), a leading cause of blindness, is rapidly increasing in prevalence due to Japan's aging population. As the market for AMD treatments expands, there is a rising demand for advanced medical devices and pharmaceuticals aimed at slowing down or halting the progression of retinal diseases.
The primary types of treatments in this market include anti-VEGF therapies, corticosteroids, and laser therapies, which are used to manage AMD and other retinal conditions such as diabetic retinopathy and retinal vein occlusion. Anti-VEGF drugs, such as Lucentis and Eylea, have become the most prescribed therapies due to their ability to inhibit abnormal blood vessel growth in the retina. This growing reliance on anti-VEGF drugs is driving demand for innovative drug delivery systems and diagnostic tools.
In addition to pharmaceutical treatments, medical devices such as retinal imaging systems, optical coherence tomography (OCT), and laser photocoagulation devices are in high demand across Japan. These devices play a crucial role in early detection, diagnosis, and monitoring of AMD, thus providing better treatment outcomes for patients.
The need for continuous innovation in the Japanese market for retinal diseases is primarily driven by the increasing burden of age-related conditions and a demand for personalized care. The market also requires collaboration between healthcare providers, industry stakeholders, and researchers to develop novel therapies and technologies. Industry professionals must prioritize precision medicine approaches and patient-centric solutions to cater to the diverse needs of Japan's aging demographic.
Furthermore, the demand for personalized healthcare solutions, including targeted therapies and patient-specific treatment plans, is expected to shape the future of the market. As the healthcare landscape evolves, the integration of artificial intelligence and machine learning in diagnostic and treatment processes is anticipated to further transform Japan’s approach to retinal diseases.
In the context of the evolving Japanese market, industries related to retinal diseases, including pharmaceuticals and medical devices, must adapt to these changing requirements. The need for high-quality solutions is clear, as market demands increase for cutting-edge treatments, devices, and services that enhance patient outcomes.
Industries looking to enter this market will find that the growing prevalence of AMD and other retinal diseases, coupled with increasing healthcare investments, makes it a promising sector to explore. The development of innovative treatments, diagnostic tools, and comprehensive care models will be essential to meet Japan's demand for advanced eye care technologies.
As with the 100 Gigabit Fiber Optic Transceiver Market, the retinal diseases market will continue to witness robust competition and ongoing advancements as companies strive to offer unique solutions that meet the specific needs of patients and healthcare providers alike.
Get an In-Depth Research Analysis of the Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size And Forecast [2025-2032]
Â
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Allergan
Santen Pharmaceutical
GlaxoSmithKline Pharmaceuticals
Pfizer
Acucela
Valent Pharmaceuticals
IVERIC
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Macular Degeneration (AMD) and Other Retinal Diseases Market
Age-related Macular Degeneration (AMD)
Diabetic Retinopathy
Macular Edema
Diabetic Macular Edema
Retinal Vein Occlusion
Macular Hole
Retinitis Pigmentosa
Other Retinal Disorders
Pharmacological Therapy
Surgical Treatment
Laser Therapy
Gene Therapy
Stem Cell Therapy
Intravitreal Injection
Topical Treatment
Oral Medications
Ocular Implant
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Homecare Settings
Fundus Photography
Optical Coherence Tomography (OCT)
Fluorescein Angiography
Ultrasound Imaging
Electroretinography (ERG)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Research Analysis
1. Introduction of the Japan Macular Degeneration (AMD) and Other Retinal Diseases Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market, By Type
6. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market, By Application
7. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/